Blanket Purchase Agreement FA860124A0009
Award Date
3/22/24
Last Date to Order
3/21/29
Federal Agency
AFLCMC Wright Patterson AFB
Awardee
Petnet Solutions, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Health Agency (DHA) awarded Petnet Solutions, Inc., a subsidiary of Siemens Aktiengesellschaft, a Blanket Purchase Agreement (BPA) contract valued at up to $2,000,000 to provide radiopharmaceuticals and supplies to support nuclear medicine services across various federal healthcare networks. Petnet Solutions is a specialized manufacturer of radioactive tracers and calibration sources used in positron emission tomography (PET) and computed tomography (CT) scans for diagnosing...
The Department of the Air Force Materiel Command Lifecycle Management Center awarded a blanket purchase agreement to Petnet Solutions, Inc. for the procurement of Axumin injections, a molecular imaging agent used in positron emission tomography scans to identify suspected prostate cancer sites. The potential value of the BPA is $250,000 with a period of performance through June 2025. Task orders issued against the BPA include orders for medical and surgical instruments, equipment, and supplies...
The Defense Health Agency awarded a single-award blanket purchase agreement to Petnet Solutions, Inc. to provide supplies and services with a potential value of $8 million. The BPA has a one-year base period of performance from September 2020 to September 2025 and was not subject to any set-aside requirements. Under this BPA, Petnet Solutions will supply the Defense Health Agency with various products and services to support its operations. Based on the description, the BPA appears aimed at...
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency to Trillamed LLC, a veteran-owned small business, to provide positron emission tomography (PET) radiopharmaceuticals to the Naval Medical Center San Diego. The $1,145,770 single-award contract has a period of performance through July 2029. Trillamed has extensive experience providing a variety of medical equipment, supplies, and related services to federal agencies, including the VA, DoD, and other healthcare...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Advanced Accelerator Applications USA Inc., a large, foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $23.4 million single-award BPA is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of February 3, 2025. The BPA is for the procurement of LOCAMETZ and NETSPOT, two...
This Blanket Purchase Agreement (BPA) is a $1,500,000.00 single-award federal contract IDV awarded by the Defense Health Agency (DHA) to the prime contractor, Sofie CO. The BPA, valid through February 27, 2029, is for the procurement of pharmaceutical supplies. Sofie CO., a subsidiary of Sofie Biosciences, Inc., is a specialized supplier of radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies, including the Department of Veterans Affairs (VA) and DHA. The...
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency Contracting Activity (DHACA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, to procure various radiopharmaceuticals for use in the Nuclear Medicine Division at Naval Medical Center San Diego (NMCSD). The single-award, firm-fixed-price BPA is valued at $1,900,000.00 and has a performance period from October 1, 2024 to September 30, 2029. The BPA covers the acquisition of 31 different...
The Defense Health Agency (DHA) awarded a Blanket Purchase Agreement (BPA) to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., for the delivery of PYLARIFY (piflufolastat F-18) injection, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. The BPA has a ceiling value of $1,000,000 and a period of performance through January 31, 2028. The contract is not set aside for small businesses. Under this BPA, the DHA...
The Defense Health Agency (DHA) has awarded a Blanket Purchase Agreement (BPA) to Medi-Physics, Inc., a subsidiary of General Electric Company (GE), to provide radiopharmaceuticals and supplies to military treatment facilities nationwide. The contract has a potential value of $1 million and a period of performance from October 1, 2020 through September 30, 2025. Under this BPA, Medi-Physics will deliver a range of radioactive tracers, medical isotopes, and diagnostic imaging agents used in...
This Blanket Purchase Agreement (BPA) is a single-award contract issued by the Department of the Air Force's Defense Finance and Accounting Service to Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft. The BPA has a potential value of $250,000 and a period of performance through January 4, 2028. The purpose of this contract is to provide chemistry analyzer servicing and laboratory testing support for the Air Force. Siemens Healthcare Diagnostics, as the prime...